Hajar Khattab
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hajar Khattab has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Asmae Sikkal
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco
3 shared publications - Bouchra El Moutawakil
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco; Laboratory of Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, Casablanca, Morocco
3 shared publications - Hicham El Otmani
Neurology Department, Ibn Rochd University Hospital Center, Casablanca, Morocco
3 shared publications - Kamal Haddouali
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco
3 shared publications - Mohamed Abdoh Rafai
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco; Research Laboratory on Nervous System Diseases, Neurosensory Diseases and Disability, Faculty of Medicine and Pharmacy, Casablanca, Morocco
3 shared publications - Salma Bellakhdar
Hassan II University of Casablanca, Faculty of Medicine and Pharmacy of Casablanca, Rue Tarik Ibn Ziad, Casablanca, 20100, Morocco; Department of Neurology, CHU Ibn Rochd, Casablanca, Morocco; Laboratory of Genetics and Molecular Pathology, Faculty of Medicine and Pharmacy, Casablanca, Morocco
3 shared publications
Latest Publications
- 22 June 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 112, 107337
Economic and social burden of multiple sclerosis in Morocco: a tertiary care center study
- 22 June 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 112, 107337
Economic and social burden of multiple sclerosis in Morocco: a tertiary care center study
- Open Access
- 23 March 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (3) , omag016
Paroxysmal motor signs in multiple sclerosis: an illustrative videotaped case
Multiple sclerosis (MS) presents with a wide spectrum of neurological manifestations, among which paroxysmal motor phenomena remain a diagnostic and therapeutic challenge. We report the case of a 29-year-old male diagnosed with relapsing–remitting MS (RRMS) who exhibited episodes of paroxysmal dystonia, dysarthria-ataxia, and ptosis. Brain MRI revealed multiple demyelinating plaques, including a contrast-enhancing lesion in the right midbrain, which provides an anatomical correlation with the patient's neurological manifestation. The dystonic movements resolved with corticosteroid therapy, while symptomatic management with carbamazepine was required for dysarthria-ataxia. Ocrelizumab has been proposed as a long-term disease-modifying treatment. This case highlights the importance of recognizing paroxysmal motor signs in MS for early diagnosis and tailored management, despite their elusive pathogenesis.
- 23 March 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (3) , omag016
Open AccessParoxysmal motor signs in multiple sclerosis: an illustrative videotaped case
Multiple sclerosis (MS) presents with a wide spectrum of neurological manifestations, among which paroxysmal motor phenomena remain a diagnostic and therapeutic challenge. We report the case of a 29-year-old male diagnosed with relapsing–remitting MS (RRMS) who exhibited episodes of paroxysmal dystonia, dysarthria-ataxia, and ptosis. Brain MRI revealed multiple demyelinating plaques, including a contrast-enhancing lesion in the right midbrain, which provides an anatomical correlation with the patient's neurological manifestation. The dystonic movements resolved with corticosteroid therapy, while symptomatic management with carbamazepine was required for dysarthria-ataxia. Ocrelizumab has been proposed as a long-term disease-modifying treatment. This case highlights the importance of recognizing paroxysmal motor signs in MS for early diagnosis and tailored management, despite their elusive pathogenesis.
- Open Access
- 24 December 2025
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2025 (12)
Paraneoplastic progressive Supranuclear palsy: a case report and literature review
Progressive supranuclear palsy-Richardson syndrome (PSP-RS) is a sporadic atypical parkinsonian disorder typically resistant to levodopa. While most cases are neurodegenerative, various conditions (genetic, vascular, infectious, or paraneoplastic) can mimic this phenotype, termed PSP-like or PSP mimics. Although paraneoplastic PSP is extremely rare, it is important to recognize because of its potential reversibility. The diagnosis can be particularly challenging, especially when classical tumor markers or imaging fail to identify a clear neoplastic origin. Here, we describe a 39-year-old man with an Anti-Ri–mediated PSP-like syndrome in whom an extensive evaluation, including surgical removal of two suspicious sites (thymus and testis), failed to identify an underlying tumor. The patient presented with rapidly progressive symptoms characteristic of PSP-RS, raising clinical suspicion for a paraneoplastic cause. We also review the literature on paraneoplastic PSP.
- 24 December 2025
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2025 (12)
Open AccessParaneoplastic progressive Supranuclear palsy: a case report and literature review
Progressive supranuclear palsy-Richardson syndrome (PSP-RS) is a sporadic atypical parkinsonian disorder typically resistant to levodopa. While most cases are neurodegenerative, various conditions (genetic, vascular, infectious, or paraneoplastic) can mimic this phenotype, termed PSP-like or PSP mimics. Although paraneoplastic PSP is extremely rare, it is important to recognize because of its potential reversibility. The diagnosis can be particularly challenging, especially when classical tumor markers or imaging fail to identify a clear neoplastic origin. Here, we describe a 39-year-old man with an Anti-Ri–mediated PSP-like syndrome in whom an extensive evaluation, including surgical removal of two suspicious sites (thymus and testis), failed to identify an underlying tumor. The patient presented with rapidly progressive symptoms characteristic of PSP-RS, raising clinical suspicion for a paraneoplastic cause. We also review the literature on paraneoplastic PSP.